We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£325.00
It has never been this cheap. We have no record of a lower price.
£325 today · cheaper than every other day in the last 3 months
NSCLC Therapeutics Outlook in Asia (2013-2018) Study
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 25 days · 25 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 25 days • 1 price levels
Price Analysis
Most common price: £325 (25 days, 100.0%)
Price range: £325 - £325
Price levels: 1 different prices over 25 days
Description
Key Features
Provides detailed estimates for latent demand and potential industry earnings (P.I.E.) in millions of U.S. dollars.
Includes comparative benchmarks showing the percent share of each country relative to the region and the globe.
Utilizes econometric models to project fundamental economic dynamics within and across different countries.
Covers a specific outlook period for non-small cell lung cancer therapeutics in Asia from 2013 to 2018.
Product Specifications
- Format
- paperback
- ASIN
- B00E4DVLPM
- Domain
- Amazon UK
- Release Date
- 17 July 2013
- Listed Since
- 24 July 2013
Similar Products You Might Like
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in Japan
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes
Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China
The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City
The 2016 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes
The 2025-2030 World Outlook for Non-Small Cell Lung Cancers
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
